SQS yields 8.20% · JNJ yields 2.13%● Live data
📍 SQS pulled ahead of the other in Year 1
Combined, SQS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SQS + JNJ for your $10,000?
SQS is an actively managed ETF aiming for long-term total return by investing in companies expected to benefit from long-term themes and areas of change or growth. The fund selects companies with quality and growth characteristics across sectors. It starts by identifying catalysts believed to drive sustained growth over time, including broad trends or transformations reshaping the economy, labor markets, capital flows, or productivity (e.g., technological innovation, demographic shifts, policy changes, or evolving market conditions). It excludes sectors expected to be negatively affected and chooses companies likely to benefit from these themes. Screening involves quantitative and fundamental analysis, using a bottom-up approach to evaluate financial health, business fundamentals, and management. The fund may also invest in ETFs. As an actively managed ETF, the manager has full discretion to adjust holdings at any time, including quality and growth requirements.
Full SQS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.